{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:14:22Z","timestamp":1791648862581,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11916-025-01411-1","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T10:19:44Z","timestamp":1750414784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Low Dose Naltrexone In The Management Of Chronic Pain Syndrome: A Meta-Analysis Of Randomized Controlled Clinical Trials"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4983-122X","authenticated-orcid":false,"given":"Naveen Chandrashekar","family":"Hegde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5476-9679","authenticated-orcid":false,"given":"Divya","family":"V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rituparna","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7339-1773","authenticated-orcid":false,"given":"Debasish","family":"Hota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"issue":"36","key":"1411_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","volume":"67","author":"J Dahlhamer","year":"2018","unstructured":"Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"1411_CR2","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","volume":"161","author":"SN Raja","year":"2020","unstructured":"Raja SN, Carr DB, Cohen M, et al. The revised international association for the study of pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976\u201382.","journal-title":"Pain"},{"issue":"10289","key":"1411_CR3","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","volume":"397","author":"SP Cohen","year":"2021","unstructured":"Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082\u201397.","journal-title":"Lancet"},{"issue":"6","key":"1411_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/jama.2013.13805","volume":"310","author":"CJ Murray","year":"2013","unstructured":"Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990\u20132010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591\u2013608.","journal-title":"JAMA"},{"issue":"4","key":"1411_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","volume":"33","author":"J Younger","year":"2014","unstructured":"Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33(4):451\u20139.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1411_CR6","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/S2665-9913(23)00278-3","volume":"6","author":"K Due Bruun","year":"2024","unstructured":"Due Bruun K, Christensen R, Amris K, et al. Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial. Lancet Rheumatol. 2024;6(1):e31\u20139.","journal-title":"Lancet Rheumatol"},{"issue":"12","key":"1411_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.adaj.2020.08.019","volume":"151","author":"E Hatfield","year":"2020","unstructured":"Hatfield E, Phillips K, Swidan S, Ashman L. Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review. J Am Dent Assoc. 2020;151(12):891-902 e1.","journal-title":"J Am Dent Assoc"},{"issue":"6","key":"1411_CR8","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.4049\/jimmunol.173.6.3916","volume":"173","author":"JK Olson","year":"2004","unstructured":"Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol. 2004;173(6):3916\u201324.","journal-title":"J Immunol"},{"issue":"11","key":"1411_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tips.2009.08.002","volume":"30","author":"LR Watkins","year":"2009","unstructured":"Watkins LR, Hutchinson MR, Rice KC, Maier SF. The \u201ctoll\u201d of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci. 2009;30(11):581\u201391.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"1411_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbi.2008.08.004","volume":"23","author":"L Del Valle","year":"2009","unstructured":"Del Valle L, Schwartzman RJ, Alexander G. Spinal cord histopathological alterations in a patient with longstanding complex regional pain syndrome. Brain Behav Immun. 2009;23(1):85\u201391.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"1411_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1460-9568.2008.06321.x","volume":"28","author":"MR Hutchinson","year":"2008","unstructured":"Hutchinson MR, Zhang Y, Brown K, et al. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur J Neurosci. 2008;28(1):20\u20139.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"1411_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.mehy.2008.06.048","volume":"72","author":"N Brown","year":"2009","unstructured":"Brown N, Panksepp J. Low-dose naltrexone for disease prevention and quality of life. Med Hypotheses. 2009;72(3):333\u20137.","journal-title":"Med Hypotheses"},{"issue":"1","key":"1411_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/BF02431530","volume":"96","author":"JD Greeley","year":"1988","unstructured":"Greeley JD, Le AD, Poulos CX, Cappell H. \u201cParadoxical\u201d analgesia induced by naloxone and naltrexone. Psychopharmacology. 1988;96(1):36\u20139.","journal-title":"Psychopharmacology"},{"issue":"4","key":"1411_CR14","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.1572-0241.2007.01045.x","volume":"102","author":"JP Smith","year":"2007","unstructured":"Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS. Low-dose naltrexone therapy improves active Crohn\u2019s disease. Am J Gastroenterol. 2007;102(4):820\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1411_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.37734","volume":"65","author":"J Younger","year":"2013","unstructured":"Younger J, Noor N, McCue R, Mackey S. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. 2013;65(2):529\u201338.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1411_CR16","first-page":"409","volume":"73","author":"TMH Paula","year":"2023","unstructured":"Paula TMH, Castro MS, Medeiros LF, et al. Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia: a randomized, double-blinded, parallel clinical trial. Braz J Anesthesiol. 2023;73(4):409\u201317.","journal-title":"Braz J Anesthesiol"},{"issue":"5","key":"1411_CR17","first-page":"468","volume":"45","author":"B Beaudette-Zlatanova","year":"2023","unstructured":"Beaudette-Zlatanova B, Lew RA, Otis JD, et al. Pilot study of low-dose naltrexone for the treatment of chronic pain due to arthritis: A randomized, double-blind, placebo-controlled. Crossover Clinical Trial Clin Ther. 2023;45(5):468\u201377.","journal-title":"Crossover Clinical Trial Clin Ther"},{"key":"1411_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jtos.2020.12.003","volume":"20","author":"G Dieckmann","year":"2021","unstructured":"Dieckmann G, Ozmen MC, Cox SM, Engert RC, Hamrah P. Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain. Ocul Surf. 2021;20:33\u20138.","journal-title":"Ocul Surf"},{"issue":"10","key":"1411_CR19","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/1753-0407.13202","volume":"13","author":"A Srinivasan","year":"2021","unstructured":"Srinivasan A, Dutta P, Bansal D, Chakrabarti A, Bhansali AK, Hota D. Efficacy and safety of low-dose naltrexone in painful diabetic neuropathy: A randomized, double-blind, active-control, crossover clinical trial. J Diabetes. 2021;13(10):770\u20138.","journal-title":"J Diabetes"},{"issue":"3","key":"1411_CR20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/phar.2086","volume":"38","author":"DK Patten","year":"2018","unstructured":"Patten DK, Schultz BG, Berlau DJ. The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, crohn\u2019s disease, and other chronic pain disorders. Pharmacotherapy. 2018;38(3):382\u20139.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"1411_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"},{"issue":"1","key":"1411_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.","journal-title":"Syst Rev"},{"issue":"4","key":"1411_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, Rucker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153\u201360.","journal-title":"Evid Based Ment Health"},{"issue":"7651","key":"1411_CR24","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Kunz R, et al. What is \u201cquality of evidence\u201d and why is it important to clinicians? BMJ. 2008;336(7651):995\u20138.","journal-title":"BMJ"},{"issue":"2","key":"1411_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ana.22006","volume":"68","author":"BA Cree","year":"2010","unstructured":"Cree BA, Kornyeyeva E, Goodin DS. Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis. Ann Neurol. 2010;68(2):145\u201350.","journal-title":"Ann Neurol"},{"issue":"2","key":"1411_CR26","doi-asserted-by":"publisher","first-page":"e0297948","DOI":"10.1371\/journal.pone.0297948","volume":"19","author":"JI Tsui","year":"2024","unstructured":"Tsui JI, Rossi SL, Cheng DM, et al. Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems. PLoS ONE. 2024;19(2):e0297948.","journal-title":"PLoS ONE"},{"issue":"4","key":"1411_CR27","doi-asserted-by":"publisher","first-page":"e1080","DOI":"10.1097\/PR9.0000000000001080","volume":"8","author":"K Bested","year":"2023","unstructured":"Bested K, Jensen LM, Andresen T, et al. Low-dose naltrexone for treatment of pain in patients with fibromyalgia: a randomized, double-blind, placebo-controlled, crossover study. Pain Rep. 2023;8(4):e1080.","journal-title":"Pain Rep"},{"issue":"1","key":"1411_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40122-020-00210-3","volume":"10","author":"A Liampas","year":"2021","unstructured":"Liampas A, Rekatsina M, Vadalouca A, Paladini A, Varrassi G, Zis P. Pharmacological management of painful peripheral neuropathies: A systematic review. Pain Ther. 2021;10(1):55\u201368.","journal-title":"Pain Ther"},{"issue":"10","key":"1411_CR29","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1093\/pm\/pnaa001","volume":"21","author":"K Bruun-Plesner","year":"2020","unstructured":"Bruun-Plesner K, Blichfeldt-Eckhardt MR, Vaegter HB, Lauridsen JT, Amris K, Toft P. Low-dose naltrexone for the treatment of fibromyalgia: Investigation of dose-response relationships. Pain Med. 2020;21(10):2253\u201361.","journal-title":"Pain Med"},{"issue":"144","key":"1411_CR30","first-page":"197","volume":"26","author":"Z Oaks","year":"2018","unstructured":"Oaks Z, Stage A, Middleton B, Faraone S, Johnson B. Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone. Discov Med. 2018;26(144):197\u2013206.","journal-title":"Discov Med"},{"issue":"2","key":"1411_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/biomedicines5020016","volume":"5","author":"L Parkitny","year":"2017","unstructured":"Parkitny L, Younger J. Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia. Biomedicines. 2017;5(2):16.","journal-title":"Biomedicines"},{"key":"1411_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4236\/pst.2023.113003","volume":"11","author":"SC HaroutiunHamzoian","year":"2023","unstructured":"HaroutiunHamzoian SC. Efficacy of low dose naltrexone on pain reduction in chronic pain syndromes: A meta analysis. Pain Studies Treatment. 2023;11:15\u201325.","journal-title":"Pain Studies Treatment"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-025-01411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-025-01411-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-025-01411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:05:21Z","timestamp":1771275921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-025-01411-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1411"],"URL":"https:\/\/doi.org\/10.1007\/s11916-025-01411-1","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"11 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"96"}}